Long-term Omalizumab efficacy in allergic rhinitis.

CONCLUSION: Long-term therapy with Omalizumab was effective and safe in treating severe persistent allergic rhinitis and concomitant asthma. PMID: 32798500 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32798500?dopt=Abstract

Source: Immunology Letters - August 12, 2020 Category: Allergy & Immunology Authors: Cavaliere C, Begvarfaj E, Incorvaia C, Sposato B, Brunori M, Ciofalo A, Greco A, de Vincentiis M, Masieri S Tags: Immunol Lett Source Type: research